Department of Defense January 13, 2014 – Federal Register Recent Federal Regulation Documents

Proposed Collection; Comment Request
Document Number: 2014-00361
Type: Notice
Date: 2014-01-13
Agency: Department of Defense, Office of the Secretary
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Assistant Secretary of Defense for Health Affairs announces a proposed public information collection and seeks public comment on the provisions thereof. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed information collection; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology.
Submission for OMB Review; Comment Request
Document Number: 2014-00358
Type: Notice
Date: 2014-01-13
Agency: Defense Acquisition Regulations System, Department of Defense
Submission for OMB Review; Comment Request
Document Number: 2014-00355
Type: Notice
Date: 2014-01-13
Agency: Defense Acquisition Regulations System, Department of Defense
Privacy Act of 1974; System of Records
Document Number: 2014-00351
Type: Notice
Date: 2014-01-13
Agency: Department of Defense, Department of the Navy
The Department of the Navy is deleting a system of records notice in its existing inventory of record systems subject to the Privacy Act of 1974, as amended. The system notice is entitled ``N03501-1, FBM Submarine DASO Crew Evaluation''.
Proposed Collection; Comment Request
Document Number: 2014-00296
Type: Notice
Date: 2014-01-13
Agency: Department of Defense, Office of the Secretary
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Assistant Secretary of Defense for Health Affairs announces a proposed public information collection and seeks public comment on the provisions thereof. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed information collection; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology.
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Anti-Filovirus Therapeutics
Document Number: 2014-00290
Type: Notice
Date: 2014-01-13
Agency: Department of Defense, Department of the Army
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/761,942, entitled ``Anti-Filovirus Therapeutics,'' filed on February 7, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Low Fat, High Protein, High Carbohydrate Complete Enteral Nutritional Compositions for Treatment of Burn Patients
Document Number: 2014-00287
Type: Notice
Date: 2014-01-13
Agency: Department of Defense, Department of the Army
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/733,938, entitled ``Low Fat, High Protein, High Carbohydrate Complete Enteral Nutritional Compositions for Treatment of Burn Patients,'' filed on December 6, 2012. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Imidazenil, or a Combination of Imidazenil and [+]-Huperzine A and/or [-]-Huperzine A for Protection Against and/or Treatment of Seizure/Status Epilepticus and Neuropathology Following Nerve Agent or Organophosphate Exposure, Compositions and Kits
Document Number: 2014-00286
Type: Notice
Date: 2014-01-13
Agency: Department of Defense, Department of the Army
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/726,753, entitled ``Imidazenil, or a Combination of Imidazenil and [+]-Huperzine A and/or [-]-Huperzine A for Protection Against and/or Treatment of Seizure/Status Epilepticus and Neuropathology Following Nerve Agent or Organophosphate Exposure, Compositions and Kits,'' filed on November 15, 2012. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Contact Pathway and Tissue Kallikrein Inhibitors Can Prevent/Reduce Leakage Caused by Hantavirus
Document Number: 2014-00285
Type: Notice
Date: 2014-01-13
Agency: Department of Defense, Department of the Army
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/851,573, entitled ``Contact Pathway and Tissue Kallikrein Inhibitors can Prevent/Reduce Leakage Caused by Hantavirus,'' filed on March 15, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Measurements of the Inhibition of Synaptic Activity (MISA) To Detect, Study and Evaluate All Active Botulinum Neurotoxin Serotypes
Document Number: 2014-00283
Type: Notice
Date: 2014-01-13
Agency: Department of Defense, Department of the Army
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/851,599, entitled ``Measurements of the Inhibition of Synaptic Activity (MISA) to Detect, Study and Evaluate All Active Botulinum Neurotoxin Serotypes,'' filed on March 8, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.